Are there risk factors for scleroderma-related calcinosis?

References

• Steen VD, Ziegler GL, Rodnan GP, Medsger TA Jr. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984;27(2):125–31.
   PubMed Web of Science ®Google Scholar
• Balin SJ, Wetter DA, Andersen LK, Davis MD. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996–2009. Arch Dermatol. 2012;148(4):455–62.
   PubMedGoogle Scholar
• Hsu V, Bramwit M, Schlesinger N. Use of dual energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosis. Clin Rheumatol. 2015;34(9):1557–61.
   PubMed Web of Science ®Google Scholar
• Hsu V, Emge T, Schlesinger N. X-ray diffraction analysis of spontaneously draining calcinosis from scleroderma patients. Scand J Rheumatol. 2016;46(2):118–21.
   PubMed Web of Science ®Google Scholar
• Moore SE, Jump AA, Smiley JD. Effect of warfarin sodium therapy on excretion of 4-carboxy-l-glutamic acid in scleroderma, dermatomyositis, and myositis ossificans progressive. Arthritis Rheum. 1986;29(3):344–51.
   PubMed Web of Science ®Google Scholar
• Cukierman T, Elinav E, Korem M, Chajek-Shaul T. Low dose warfarin treatment for calcinosis in patients with systemic sclerosis. Ann Rheum Dis. 2004;63(10):1341–3.
   PubMed Web of Science ®Google Scholar
• Lassoued K, Saiag P, Anglade MC, Roujeau JC, Touraine RL. Failure of warfarin in treatment of calcinosis universalis. Am J Med. 1988;84(4):795–6.
   PubMed Web of Science ®Google Scholar
• Dolan AL, Kassimos D, Gibson T, Kingsley GH. Diltiazem induces remission of calcinosis in scleroderma. Br J Rheumatol. 1995;34(6):576–8.
   PubMedGoogle Scholar
• Robertson LP, Marshall RW, Hickling P. Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline. Ann Rheum Dis. 2003;62(3):267–9.
   PubMed Web of Science ®Google Scholar
• Fujii N, Hamano T, Isaka Y, Ito T, Imai E. Risedronate: a possible treatment for extraosseous calcification. Clin Calcium. 2005;1(15):75–8.
   Google Scholar
• Schanz S, Ulmer A, G. Fierlbeck G. Response of dystrophic calcification to intravenous immunoglobulin. Arch Dermatol. 2008;144(5):585–7.
   PubMedGoogle Scholar
• Fuchs D, Fruchter L, Fishel B, Holtzman M, Yaron M. Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis. Clin Rheumatol. 1986;5(4):527–30.
   PubMed Web of Science ®Google Scholar
• Bogoch ER, Gross DK. Surgery of the hand in patients with systemic sclerosis: outcomes and considerations. J Rheumatol. 2005;32(4):642–8.
   PubMed Web of Science ®Google Scholar
• Chamberlain AJ, Walker NP. Successful palliation and significant remission of cutaneous calcinosis in CREST syndrome with carbon dioxide laser. Dermatol Surg. 2003;29(9):968–70.
   PubMed Web of Science ®Google Scholar
• Gerdesmeyer L, Wagenpfeil S, Haake M, Maier M, Loew M, Wortler K, et al. Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA. 2003;290(19):2573–80.
   PubMed Web of Science ®Google Scholar
• Daoussis D, Liossis SN, Yiannopoulos G, Andonopoulos AP. B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence. Int J Rheumatol. 2011;2011:214013.
   PubMedGoogle Scholar
• Poormoghim H, Andalib E, Almasi AR, Hadibigi E. Systemic sclerosis and calcinosis cutis: response to Rituximab. J Clin Pharm Ther. 2016;41(1):94–6.
   PubMed Web of Science ®Google Scholar
• Valenzuela A, Chung L. Calcinosis: pathophysiology and management. Curr Opin Rheumatol. 2015;27(6):542–8.
   PubMed Web of Science ®Google Scholar
• Hoogen FVD, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747–55. and Arthritis Rheum. 2013;65(11):2737–57.
   PubMed Web of Science ®Google Scholar
• Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am. 2002;28(4):723–41.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
   PubMed Web of Science ®Google Scholar
• Kasukawa R. Mixed connective tissue disease. Intern Med. 1999;38:386–93.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold video-capillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27:155–60.
   PubMed Web of Science ®Google Scholar
• Vayssairat M, Hidouche D, Abdoucheli-Baudot N, Gaitz JP. Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression? Ann Rheum Dis. 1998;57(4):252–4.
   PubMed Web of Science ®Google Scholar
• Avouac J, Guerini H, Wipff J, Assous N, Chevrot A, Kahan A, et al. Radiological hand involvement in systemic sclerosis. Ann Rheum Dis. 2006;65(8):1088–92.
   PubMed Web of Science ®Google Scholar
• Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR. Low bone density in systemic sclerosis. A systematic review. J Rheumatol. 2013;40(11):1881–90.
   PubMed Web of Science ®Google Scholar
• Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Pitaro N, Latorraca A, et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol. 1995;14(4):407–12.
   PubMed Web of Science ®Google Scholar
• Valenzuela A, Baron M, Herrick AC, Proudman S, Stevens W, Rodriguez-Reyna TS, et al. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a Scleroderma Clinical Trials Consortium study. Semin Arthritis Rheum. 2016;46(3):344–9.
   PubMed Web of Science ®Google Scholar
• Simeon-Aznar CP, Fonollosa-Pla V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, et al. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum. 2012;41(6):789–800.
   PubMed Web of Science ®Google Scholar
• Brandler WM, Morris AP, Evans DM, Scerri TS, Kemp JP, Timpson NJ, et al. Common variants in left/right asymmetry genes and pathways are associated with relative hand skill. PLoS Genet. 2013;9(9):e1003751.
   PubMed Web of Science ®Google Scholar
• Gauber R, Wilkinson J, Harris J, Manning J, Herrick AL. Calcinosis preferentially affects the thumb compared to other fingers in patients with systemic sclerosis. Scand J Rheumatol. 2016;45(4):317–20.
   PubMed Web of Science ®Google Scholar
• Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005;34:805–12.
   PubMed Web of Science ®Google Scholar
• Nitsche A. Raynaud, digital ulcers and calcinosis in scleroderma. Reumatol Clin. 2012;8(5):270.
   PubMedGoogle Scholar
• Baron M, Pope J, Robinson D, Jones N, Khalidi N, Docherty P, et al. Calcinosis is associated with digital ischemia in systemic sclerosis – a longitudinal study. Rheumatology (Oxford). 2016;55(12):2148–55.
   PubMed Web of Science ®Google Scholar